BMS 524

Generic Name: dasatinib

Pill imprint BMS 524 has been identified as Sprycel 70 mg.

Sprycel is used in the treatment of chronic myelogenous leukemia; leukemia; acute lymphoblastic leukemia and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy.

Sprycel 70 mg is not subject to the Controlled Substances Act.
See also related documents.

Sprycel Images

Generic Name:
dasatinib
Imprint:
BMS
524
Strength:
70 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Inactive Ingredients:
croscarmellose sodium
hydroxypropyl cellulose
hypromelloses
polyethylene glycol
lactose monohydrate
microcrystalline cellulose
magnesium stearate
titanium dioxide
Drug Class:
BCR-ABL tyrosine kinase inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Bristol-Myers Squibb
National Drug Code (NDC):
00003-0524

View Drug DetailsPrint Page

Sprycel 70 mg BMS 524
Advertisement

Sprycel is associated with the treatment of:

Search Again

Search by Imprint, Shape or Color

Note: All fields optional. Use the pill finder to identify medications by visual appearance or name.

Imprint:
Color:
Shape:

Search by Drug Name

Drug Name:

Search by National Drug Codes (NDC)

Did you find this page helpful? Yes No

(web4)